Michiel Coppens

8.5k citations

134 papers · 4.5k indexed · 3 hit papers · h-index 29

Impact in

Internal Medicine top 0.1%
- Venous Thromboembolism Diagnosis and Management
Hematology top 0.5%
- Blood Coagulation and Thrombosis Mechanisms
- Hemophilia Treatment and Research
- Platelet Disorders and Treatments

Papers in

Internal Medicine 49
- Venous Thromboembolism Diagnosis and Management 49
Hematology 75
- Hemophilia Treatment and Research 47
- Blood Coagulation and Thrombosis Mechanisms 31
- Platelet Disorders and Treatments 24

Co-authors: Saskia Middeldorp Nick van Es Harry R. Büller Sam Schulman Alexander P. J. Vlaar Ludo F.M. Beenen Marcella C.A. Müller Loek P. Smits
Journals: Journal of Thrombosis and Haemostasis (20 papers)Blood (19 papers)Research and Practice in Thrombosis and Haemostasis (14 papers)Haemophilia (9 papers)Thrombosis and Haemostasis (7 papers)
Partner nations: Netherlands Germany United States

In The Last Decade

Michiel Coppens

126 papers receiving 4.4k citations

Hit Papers

align trajectories log scale

American Society of Hematology 2023 guidelines for management of venous thromboembolism: thrombophilia testing 2023 · 92 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2023 Blood Advances
2020 Journal of Thrombosis and Haemostasis
2014 Blood

Peers

Countries citing papers authored by Michiel Coppens

Since Specialization

Citations

This map shows the geographic impact of Michiel Coppens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michiel Coppens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michiel Coppens more than expected).

Fields of papers citing papers by Michiel Coppens

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michiel Coppens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michiel Coppens. The network helps show where Michiel Coppens may publish in the future.

Co-authors

The 25 scholars most cited alongside Michiel Coppens, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michiel Coppens Line = papers co-authored together Michiel Coppens links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Peri‐operative desmopressin combined with pharmacokinetic‐guided factor VIII concentrate in non‐severe haemophilia A patients Haemophilia ·Sheeba Sagar, Bian'an Zhu, Reinier M. van Hest, Karina Meijer, Britta A. P. Laros‐van Gorkom, Laurens Nieuwenhuizen, Jeroen Eikenboom, Floor Heubel-Moenen, Dagmar Ellerbrock, Michiel Coppens, Karin Fijnvandraat, M.H.E. Driessens, Suzanne Polinder, Marjon H. Cnossen, Frank W.G. Leebeek, Ron A. A. Mathôt, Marieke J. H. A. Kruip	2024	0
2	In patients with hemophilia, a decreased thrombin generation profile is associated with a severe bleeding phenotype Research and Practice in Thrombosis and Haemostasis ·誠杉光, Waander L. van Heerde, Johanna G. van der Bom, Erik A.M. Beckers, Nicole M. A. Blijlevens, Michiel Coppens, Samantha C. Gouw, Joop H. Jansen, Frank W.G. Leebeek, Lize F. D. van Vulpen, Daniëlle Meijer, Saskia E.M. Schols	2023	12
3	A new population pharmacokinetic model for recombinant factor IX‐Fc fusion concentrate including young children with haemophilia B British Journal of Clinical Pharmacology ·Sarahbeth Purcell, J Klimcík, 金汝平, B. Strusievici, Frank W.G. Leebeek, Karin Fijnvandraat, Michiel Coppens, Mary Mathias, Peter W. Collins, Robert C. Tait, Catherine Bagot, Nicola Curry, Jeanette Payne, Pratima Chowdary, Marjon H. Cnossen, Ron A. A. Mathôt	2023	3
4	Transition readiness among adolescents and young adults with haemophilia in the Netherlands: Nationwide questionnaire study Haemophilia ·Alvin Gumelar Hanevi, Ebogo SW, Marjon H. Cnossen, Cees Smit, Lize F. D. van Vulpen, Paul van der Valk, Jeroen Eikenboom, Floor Heubel-Moenen, Wonbae Son, Paula F. Ypma, Laurens Nieuwenhuizen, Michiel Coppens, Saskia E.M. Schols, Britta A. P. Laros‐van Gorkom, Frank W.G. Leebeek, M.H.E. Driessens, Frits R. Rosendaal, Johanna G. van der Bom, Karin Fijnvandraat, Samantha C. Gouw	2023	0
5	Desmopressin for bleeding in non‐severe hemophilia A: Suboptimal use in a real‐world setting Research and Practice in Thrombosis and Haemostasis ·Audrey L. Chai, Deying Su, Michiel Coppens, Samantha C. Gouw, Sara Boyce, Catherine Bagot, Erik A.M. Beckers, Paul Brons, Giancarlo Castaman, Jeroen Eikenboom, Shannon Jackson, Marieke J. H. A. Kruip, Frank W.G. Leebeek, Karina Meijer, Laurens Nieuwenhuizen, Ingrid Pabinger, Karin Fijnvandraat	2022	7
6	Modeling Benefits, Costs, and Affordability of a Novel Gene Therapy in Hemophilia A White Rose Research Online (University of Leeds, The University of Sheffield, University of York) ·Renske M.T. ten Ham, Paul R. Calandra, Marta Soares, Geert Frederix, Frank W.G. Leebeek, Kathelijn Fischer, Michiel Coppens, Stephen Palmer	2022	14
7	Joint status of patients with nonsevere hemophilia A Journal of Thrombosis and Haemostasis ·Audrey L. Chai, Deying Su, Robert Hemke, Samantha C. Gouw, Michiel Coppens, Sheeba Sagar, Marieke J. H. A. Kruip, Marjon H. Cnossen, Frank W.G. Leebeek, Barbara A. Hutten, Mario Maas, Karin Fijnvandraat	2022	23
8	Hepatitis C virus in hemophilia: Health‐related quality of life after successful treatment in the sixth Hemophilia in the Netherlands study Research and Practice in Thrombosis and Haemostasis ·Ramón Trías, Samantha C. Gouw, Erna C. van Balen, Солуянов Никита Степанович, Erik A.M. Beckers, Johanna G. van der Bom, Michiel Coppens, Jeroen Eikenboom, Kathelijn Fischer, Wonbae Son, Frank W.G. Leebeek, Frits R. Rosendaal, Saskia E.M. Schols, Cees Smit, Lize F. D. van Vulpen, Eveline P. Mauser‐Bunschoten	2021	5
9	Clinical implications and cost-effectiveness analysis of rivaroxaban in patients with coronary artery disease or peripheral arterial disease in the Netherlands Journal of Medical Economics ·Jennifer M. Myskowski, J Brière, Kevin Bowrin, A. Millier, Michiel Coppens, K. Baèeva, Kuzmin Anton	2021	4
10	Similar sports participation as the general population in Dutch persons with haemophilia; results from a nationwide study Haemophilia ·A. K. Zaalouk, Erna C. van Balen, Солуянов Никита Степанович, Saskia E.M. Schols, Frank W.G. Leebeek, Jeroen Eikenboom, Michiel Coppens, Lize F. D. van Vulpen, Cees Smit, M.H.E. Driessens, Janjaap van der Net, Samantha C. Gouw, Kathelijn Fischer	2021	13
11	Incidence of venous thromboembolism in hospitalized patients with COVID‐19 Journal of Thrombosis and Haemostasis ·Saskia Middeldorp, Michiel Coppens, Thijs F. van Haaps, Merijn Foppen, Alexander P. J. Vlaar, Marcella C.A. Müller, Catherine Bouman, Ludo F.M. Beenen, Ruud S. Kootte, Jarom Heijmans, Loek P. Smits, Peter I. Bonta, Nick van Es Hit paper breakdown →	2020	1017
12	Intracranial hemorrhage with direct oral anticoagulants in patients with brain metastases Blood Advances ·Avi Leader, Eva N. Hamulyák, Minh Hoang Bui, Elena Petrovna Matafonova, Gonca Akdeniz, KS Lau, Ludo F.M. Beenen, Shlomit Yust‐Katz, Г.Ш. Казыханова, Michiel Coppens, Pia Raanani, Saskia Middeldorp, Harry R. Büller, Jeffrey I. Zwicker, Galia Spectre	2020	33
13	Determinants of the Quality of Warfarin Control after Venous Thromboembolism and Validation of the SAMe-TT2-R2 Score: An Analysis of Hokusai-VTE Thrombosis and Haemostasis ·Stefano Barco, Serena Granziera, Michiel Coppens, Jonathan Douxfils, Mathilde Nijkeuter, Nicoletta Riva, Thomas Vanassche, George Zhang, Min Lin, Pieter W. Kamphuisen, Alexander T. Cohen, Jan Beyer‐Westendorf	2019	6
14	Measurement of coagulation factors during rivaroxaban and apixaban treatment: Results from two crossover trials Research and Practice in Thrombosis and Haemostasis ·Luuk J.J. Scheres, Willem M. Lijfering, Saskia Middeldorp, Y. Whitney Cheung, Stefano Barco, Suzanne C. Cannegieter, Michiel Coppens	2018	10
15	Guidelines' risk assessment recommendations for venous thromboembolism prophylaxis: A comparison and implementability appraisal Thrombosis Research ·Алиев Джомарт Фазылович, Nikki L. Damen, О. Г. Полушин, Jie-Sheng Wang, Terry Indrayadi Tjokro, Roel Vink, Michiel Coppens, Marieke J.H.A. Kruip, Karina Meijer, Maaike Langelaan, Martine C. de Bruijne, Cordula Wagner	2018	2
16	Pharmacokinetics of dabigatran etexilate and rivaroxaban in patients with short bowel syndrome requiring parenteral nutrition: The PDER PAN study Thrombosis Research ·Y. Whitney Cheung, Stefano Barco, Ron A. A. Mathôt, Marian Oczachowski, An K. Stroobants, Mireille J. Serlie, Saskia Middeldorp, Michiel Coppens	2017	15
17	Home parenteral nutrition‐associated thromboembolic and bleeding events: results of a cohort study of 236 individuals Journal of Thrombosis and Haemostasis ·Stefano Barco, Т. В. Богдан, Don B. Simpson, Marjolein Brekelmans, Mireille J. Serlie, Saskia Middeldorp, Michiel Coppens	2016	15
18	Safety of prothrombin complex concentrate in healthy subjects British Journal of Haematology ·Stefano Barco, Catherine Girrier, Alice Trinchero, Saskia Middeldorp, Michiel Coppens	2016	3
19	In vivo reversal of the anticoagulant effect of rivaroxaban with four‐factor prothrombin complex concentrate British Journal of Haematology ·Stefano Barco, Y. Whitney Cheung, Michiel Coppens, Barbara A. Hutten, Joost C.M. Meijers, Saskia Middeldorp	2015	46
20	Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials Blood ·Nick van Es, Michiel Coppens, Sam Schulman, Saskia Middeldorp, Harry R. Büller Hit paper breakdown →	2014	581

About Michiel Coppens

Michiel Coppens is a scholar working on Internal Medicine, Hematology, Cardiology and Cardiovascular Medicine, Genetics and Emergency Medical Services, having authored 134 papers that have together received 4.5k indexed citations. Recurring topics across this work include Venous Thromboembolism Diagnosis and Management (49 papers), Hemophilia Treatment and Research (47 papers), Atrial Fibrillation Management and Outcomes (38 papers), Blood Coagulation and Thrombosis Mechanisms (31 papers), Platelet Disorders and Treatments (24 papers), Antiplatelet Therapy and Cardiovascular Diseases (13 papers), Virus-based gene therapy research (12 papers) and CAR-T cell therapy research (10 papers). The work is most often cited by research in Internal Medicine (2.0k citations), Hematology (1.4k citations), Cardiology and Cardiovascular Medicine (1.8k citations), Infectious Diseases (894 citations) and Emergency Medical Services (235 citations). Michiel Coppens has collaborated with scholars based in Netherlands, Germany and United States. Frequent co-authors include Saskia Middeldorp, Nick van Es, Harry R. Büller, Sam Schulman, Alexander P. J. Vlaar, Ludo F.M. Beenen, Marcella C.A. Müller, Loek P. Smits, Merijn Foppen and Thijs F. van Haaps. Their work appears in journals such as Journal of Thrombosis and Haemostasis, Blood, Research and Practice in Thrombosis and Haemostasis, Haemophilia and Thrombosis and Haemostasis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact